These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 25369980

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Charmandari E, Johnston A, Brook CG, Hindmarsh PC.
    J Endocrinol; 2001 Apr; 169(1):65-70. PubMed ID: 11250647
    [Abstract] [Full Text] [Related]

  • 3. Congenital adrenal hyperplasia: management during critical illness.
    Charmandari E, Lichtarowicz-Krynska EJ, Hindmarsh PC, Johnston A, Aynsley-Green A, Brook CG.
    Arch Dis Child; 2001 Jul; 85(1):26-8. PubMed ID: 11420193
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study.
    Johannsson G, Bergthorsdottir R, Nilsson AG, Lennernas H, Hedner T, Skrtic S.
    Eur J Endocrinol; 2009 Jul; 161(1):119-30. PubMed ID: 19383806
    [Abstract] [Full Text] [Related]

  • 8. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
    Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
    J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
    [Abstract] [Full Text] [Related]

  • 9. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty.
    Charmandari E, Hindmarsh PC, Johnston A, Brook CG.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2701-8. PubMed ID: 11397874
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia.
    Melin J, Parra-Guillen ZP, Michelet R, Truong T, Huisinga W, Hartung N, Hindmarsh P, Kloft C.
    J Clin Endocrinol Metab; 2020 Mar 01; 105(3):. PubMed ID: 32052005
    [Abstract] [Full Text] [Related]

  • 12. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion.
    Bryan SM, Honour JW, Hindmarsh PC.
    J Clin Endocrinol Metab; 2009 Sep 01; 94(9):3477-80. PubMed ID: 19567522
    [Abstract] [Full Text] [Related]

  • 13. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
    Lennernäs H, Skrtic S, Johannsson G.
    Expert Opin Drug Metab Toxicol; 2008 Jun 01; 4(6):749-58. PubMed ID: 18611115
    [Abstract] [Full Text] [Related]

  • 14. Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise.
    Weise M, Drinkard B, Mehlinger SL, Holzer SM, Eisenhofer G, Charmandari E, Chrousos GP, Merke DP.
    J Clin Endocrinol Metab; 2004 Aug 01; 89(8):3679-84. PubMed ID: 15292287
    [Abstract] [Full Text] [Related]

  • 15. Treatment with flutamide decreases cortisol clearance: implications for therapy in congenital adrenal hyperplasia.
    Charmandari E, Johnston A, Honour JW, Brook CG, Hindmarsh PC.
    J Pediatr Endocrinol Metab; 2002 Apr 01; 15(4):435-9. PubMed ID: 12008691
    [Abstract] [Full Text] [Related]

  • 16. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
    J Clin Endocrinol Metab; 2001 Oct 01; 86(10):4679-85. PubMed ID: 11600525
    [Abstract] [Full Text] [Related]

  • 17. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A, Liew A, Finucane F, Baker L, O'Kelly P, Tormey W, Thompson CJ.
    Clin Endocrinol (Oxf); 2004 Jun 01; 60(6):688-93. PubMed ID: 15163331
    [Abstract] [Full Text] [Related]

  • 18. Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapy.
    Peters CJ, Hill N, Dattani MT, Charmandari E, Matthews DR, Hindmarsh PC.
    Clin Endocrinol (Oxf); 2013 Mar 01; 78(3):347-51. PubMed ID: 22803584
    [Abstract] [Full Text] [Related]

  • 19. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.
    Mallappa A, Sinaii N, Kumar P, Whitaker MJ, Daley LA, Digweed D, Eckland DJ, Van Ryzin C, Nieman LK, Arlt W, Ross RJ, Merke DP.
    J Clin Endocrinol Metab; 2015 Mar 01; 100(3):1137-45. PubMed ID: 25494662
    [Abstract] [Full Text] [Related]

  • 20. Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasia.
    Ross RJ, Rostami-Hodjegan A.
    Horm Res; 2005 Mar 01; 64 Suppl 2():67-70. PubMed ID: 16286775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.